Plunkett Research Online: Monopar Therapeutics Inc

MONOPAR THERAPEUTICS INC (MNPR:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mu.....



Monopar Therapeutics Inc
Ticker: MNPR
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 847 388-0349
Fax:
Address: 1000 Skokie Boulevard
Suite 350
Wilmette, IL 60091 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing
Contacts Description
Chandler RobinsonCEO/Director
Karthik RadhakrishnanCFO/Chief Accounting Officer
See More
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mu.....See More See More

Auditor: BPM LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202320222021202020192018
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
NameTitleSalary (US$)Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: